Skip to content

InnovAge Holdings, Inc. INNV Change in Deferred Revenue

Change in Deferred Revenue at other companies

Humana logo
HumanaHUM
-$87M-1,840%
UnitedHealth Group logo
UnitedHealth GroupUNH
$20M+300%
Centene logo
CenteneCNC
$217M+4.3%
PACS Group logo
PACS GroupPACS
$0-100%

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+150%
Enterprise value$1.31B+130%
P/S1.4×+0.7×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.

The official record: InnovAge Holdings, Inc.’s 10-K, filed September 9, 2025, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s change in deferred revenue?
InnovAge Holdings, Inc. (INNV) reported change in deferred revenue of $0 in Q2 2025.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.